Microbiology Spectrum,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 5, 2025
ABSTRACT
Uncomplicated
bacteremic
urinary
tract
infections
(bUTIs)
are
common,
often
caused
by
Escherichia
coli
,
Klebsiella
pneumoniae
and
Enterococcus
faecalis
with
most
encounters
treated
empirically.
As
rates
of
antimicrobial
resistance
increase,
available
antibiotic
treatment
options
dwindling.
Novel
antibiotics
approved
for
treating
bUTIs
limited,
leading
to
a
resurgence
interest
in
older
antibiotics,
including
fosfomycin.
Here,
clinical
urine
samples
from
patients
military
personnel,
retirees,
their
dependents
diagnosed
hospital
located
Bethesda,
Maryland,
were
tested
susceptibility
fosfomycin
comparator
(levofloxacin,
nitrofurantoin,
trimethoprim-sulfamethoxazole
[TMS]).
A
total
1,353
nonduplicate
bacterial
isolates
tested,
605
non-ESBL
285
ESBL
E.
84
52
K.
.
Fosfomycin
similar
(95.9%
vs
96.1%)
(38.1%
36.5%).
demonstrated
high
activity
against
other
Enterobacterales
gram-positive
organisms
Enterobacter
Staphylococcus
aureus
Interestingly,
non-susceptible
susceptible
first-line
bUTI
options,
that
option
the
least
current
options.
Etest
sensitivity
compared
agar
dilution,
making
it
viable
AST
testing
method
especially
resource-limited
areas.
Overall,
we
has
common
etiologies
cause
bUTIs.
Further
efficacy
studies
investigating
use
non-
E
pathogens,
as
single
or
combination
therapy,
warranted.
IMPORTANCE
is
one
recommended
firstline
symptomatic,
uncomplicated
complicated
fact
although
both
CLSI
EUCAST
recognize
dilution
(AD)
reference
albeit
being
labor-intensive,
breakpoints
different,
only
EUCAST.
We
investigated
using
AD
performance
subset
Etest.
profiles
antibiotics.
found
at
higher
Importantly,
was
effective
producing
extended-spectrum
beta-lactamases
those
resistant
treatments.
Furthermore,
our
data
showed
94%
agreement
AD.
Microorganisms,
Journal Year:
2023,
Volume and Issue:
11(8), P. 1912 - 1912
Published: July 27, 2023
The
global
burden
of
bacterial
resistance
remains
one
the
most
serious
public
health
concerns.
Infections
caused
by
multidrug-resistant
(MDR)
bacteria
in
critically
ill
patients
require
immediate
empirical
treatment,
which
may
not
only
be
ineffective
due
to
MDR
multiple
classes
antibiotics,
but
also
contribute
selection
and
spread
antimicrobial
resistance.
Both
WHO
ECDC
consider
carbapenem-resistant
Enterobacteriaceae
(CRE),
Pseudomonas
aeruginosa
(CRPA),
Acinetobacter
baumannii
(CRAB)
highest
priority.
ability
form
biofilm
acquisition
drug
genes,
particular
carbapenems,
have
made
these
pathogens
particularly
difficult
treat.
They
are
a
growing
cause
healthcare-associated
infections
significant
threat
health,
associated
with
high
mortality
rate.
Moreover,
co-colonization
was
found
predictor
for
in-hospital
mortality.
Importantly,
they
potential
using
mobile
genetic
elements.
Given
current
situation,
it
is
clear
that
finding
new
ways
combat
can
no
longer
delayed.
aim
this
review
evaluate
literature
on
how
AMR.
highlights
importance
rational
use
antibiotics
need
implement
stewardship
principles
prevent
transmission
drug-resistant
organisms
healthcare
settings.
Finally,
discusses
advantages
limitations
alternative
therapies
treatment
“titans”
antibiotic
Antibiotics,
Journal Year:
2024,
Volume and Issue:
13(2), P. 154 - 154
Published: Feb. 4, 2024
Urinary
tract
infections
(UTIs)
are
prevalent
bacterial
in
both
community
and
healthcare
settings.
They
account
for
approximately
40%
of
all
require
around
15%
antibiotic
prescriptions.
Although
antibiotics
have
traditionally
been
used
to
treat
UTIs
several
decades,
the
significant
increase
resistance
recent
years
has
made
many
previously
effective
treatments
ineffective.
Biofilm
on
medical
equipment
settings
creates
a
reservoir
pathogens
that
can
easily
be
transmitted
patients.
catheter
frequently
observed
hospitals
caused
by
microbes
form
biofilm
after
is
inserted
into
bladder.
Managing
biofilms
challenging
due
emergence
resistance.
Biofilms
enable
evade
host’s
innate
immune
defences,
resulting
long-term
persistence.
The
incidence
sepsis
spread
bloodstream
increasing,
drug-resistant
may
even
more
prevalent.
While
availability
upcoming
tests
identify
cause
infection
its
spectrum
critical,
it
alone
will
not
solve
problem;
innovative
treatment
approaches
also
needed.
This
review
analyses
main
characteristics
formation
drug
recurrent
uropathogen-induced
UTIs.
importance
alternative
therapies
combatting
biofilm-caused
UTI
emphasised.
Life,
Journal Year:
2024,
Volume and Issue:
14(1), P. 106 - 106
Published: Jan. 9, 2024
Urinary
tract
infections
(UTIs)
represent
a
frequent
pathology
among
the
female
population
that
has
become
more
and
difficult
to
treat
in
past
decade,
considering
increase
antibiotic
resistance—a
serious
global
public
health
problem.
A
cross-sectional
retrospective
study
was
conducted
for
six
months
report
an
update
regarding
rates
of
resistance
susceptibility
uropathogens
necessary
optimal
treatment.
total
5487
patients
were
screened,
which
524
(9.54%)
who
met
criteria
inclusion
study.
Escherichia
coli
most
common
pathogen,
representing
290
cases
(55.34%),
followed
by
Enterococcus
spp.
82
(15.64%).
presented
highest
amoxicillin-clavulanic
acid
(R
=
33.1%),
trimethoprim-sulfamethoxazole
32.41%)
levofloxacin
32.06%).
The
sensitivity
observed
fosfomycin
(S
96.55%),
imipenem
93.1%).
showed
50.0%),
penicillin
39.02%).
90.24%),
linezolid
89.02%),
nitrofurantoin
86.58%).
second
Gram-negative
uropathogen
represented
Klebsiella
spp.,
had
35.89%),
25.64)
trimethoprim-suflamethoxazole
24.35%).
frequently
associated
episode
UTI
previous
year,
diabetes
chronic
kidney
disease.
Antibiotic
is
problem
all
clinicians
UTIs.
An
up-to-date
knowledge
major
necessity
stop
its
evolution.
Overall,
aminopenicillins,
fluoroquinolones,
trimethoprim-sulfamethoxazole.
best
fosfomycin,
nitrofurantoin,
carbapenems.
Our
aims
guide
whenever
they
are
forced
prescribe
antibiotics
empirically.
Journal of Clinical Microbiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 6, 2025
ABSTRACT
Urinary
tract
infections
(UTIs)
impose
a
substantial
burden
on
patient
quality
of
life
and
urine
testing
accounts
for
the
majority
workload
in
many
clinical
microbiology
laboratories.
Traditional
UTI
diagnosis
relies
symptoms,
urinalysis,
culture
which
are
interpreted
based
historical
guidelines.
This
approach,
while
foundational,
presents
limitations,
particularly
complex
cases.
Low-level
bacteriuria
presence
fastidious
organisms
often
overlooked
or
entirely
missed
standard
culture,
stressing
need
novel
diagnostic
methods
technologies.
mini-review
summarizes
existing
state
diagnostics
2024
covers
current
upcoming
technologies
including
rapid
molecular-based
pathogen
identification,
next-generation
sequencing,
advanced
antimicrobial
susceptibility
testing.
However,
these
represent
unique
challenges,
as
they
implemented,
will
require
field
to
adapt
new
concepts
avoid
misdiagnosis
overtreatment.
Pathogens,
Journal Year:
2025,
Volume and Issue:
14(1), P. 59 - 59
Published: Jan. 11, 2025
The
aim
of
this
study
was
to
investigate
the
differences
between
nosocomial
and
community
microorganisms
isolated
from
patients
with
UTI
by
determining
their
bacterial
profile,
antibiotic
resistance
ability
produce
biofilms.
A
retrospective
study,
based
on
isolates
consecutive
urine
samples
collected
January
2019
December
2023,
conducted
at
a
university
hospital.
main
pathogens
both
hospital
were
same,
but
frequency
isolation
differed.
Compared
community-associated
cases,
hospital-associated
infections
have
more
Acinetobacter
baumanii
complex.
In
contrast,
Proteus
mirabilis
prevalent
in
than
infections.
isolates,
gram-positive
bacteria
showed
lower
overall
antimicrobial
(22%)
compared
gram-negative
(30%).
data
demonstrated
that
individual
strains
exhibited
disparate
degrees
capacity
for
biofilm
formation.
Additionally,
indicate
an
inverse
correlation
production
resistance.
Isolates
capacities
comparison
(29%
35%,
respectively).
Area-specific
surveillance
studies
can
provide
valuable
information
patterns,
which
be
useful
guiding
empirical
treatment.
Inorganics,
Journal Year:
2025,
Volume and Issue:
13(2), P. 65 - 65
Published: Feb. 19, 2025
Proteus
mirabilis
has
been
identified
as
the
third
most
frequent
reason
for
catheter-associated
urinary
tract
infections.
The
production
of
urease
significantly
enhances
force
catheter
blockage
caused
by
biofilm
formation.
Because
biofilms
are
important
virulence
factors
that
make
antibiotics
less
potent,
it
is
becoming
increasingly
to
develop
novel
alternative
antibiotics.
In
addition
unique
properties
they
possess,
nanoparticles
made
from
metal
oxide
currently
attracting
considerable
attention
possible
antibacterials.
This
research
aims
explore
potential
anti-biofilm
green
manufactured
ZnO-CuO
generated
P.
mirabilis.
By
synthesizing
reductive
enzymes,
bacterial
cells
can
participate
in
biosynthesis
process.
study
explores
whether
synthesized
work
an
agent
formed
These
were
using
Bacteriocins
determine
their
effectiveness
against
bacteria,
which
partially
purified
and
showed
antimicrobial
activity
Gram-negative
bacteria
AFM,
TEM,
FESEM,
XRD,
ultraviolet
(UV)–visible
spectroscopy
used
analyze
biosynthesized
ascertain
chemical
physical
characteristics.
XRD
verified
hexagonal
structure,
TEM
demonstrated
a
size
range
96.00
nm,
FESEM
surface
morphology.
dispersion
roughness
shown
through
AFM
examination.
produced
nanoparticles’
UV-visible
spectra
displayed
maximum
peak
at
287
232
nm.
When
applied
strains
(wild-type)
(multidrug-resistant),
copper
zinc
had
notable
inhibitory
effects.
Weak
effectively
generate
biofilms,
following
incubation
with
128
μg/mL
subminimum
concentrations
(MICs)
CuO
24
48
h
37
°C.
Following
treatment
nanocomposite
these
strains,
downregulation
alterations
LuxS
expression
detected
utilizing
real-time
PCR
After
this,
isolates
treated
nanocomposite,
downregulated
shifts
found
technique
contrast
not
treated.
Zinc
(ZnO)
be
utilized
antibacterial
agents
concentration-dependent
manner,
aligning
all
observed
findings.
present
demonstrates
oxide–zinc
nanocomposites
effective
Their
noteworthy
gene
successfully
prevents
formation
swarming
motility.
Future Pharmacology,
Journal Year:
2023,
Volume and Issue:
3(3), P. 535 - 567
Published: July 4, 2023
The
‘post-antibiotic’
era
is
near
according
to
the
World
Health
Organization
(WHO).
It
well
known,
due
work
of
scientific
community,
that
drugs
(antibiotics,
antifungals,
and
other
antimicrobial
agents)
are
continuously
becoming
less
effective,
multidrug-resistant
(MDR)
pathogens
on
rise.
This
scenario
raises
concerns
an
impending
global
infectious
disease
crisis,
wherein
a
simple
opportunistic
infection
could
be
deadly
for
humans.
war
against
MDR
requires
innovation
multidisciplinary
approach.
present
study
provides
comprehensive
coverage
relevant
topics
concerning
new
drugs;
it
suggests
combination
different
natural
products
(such
as
plant
extracts,
honey,
propolis,
prebiotics,
probiotics,
synbiotics,
postbiotics),
together
with
drug
therapy,
used
adjuvant
in
standard
treatments,
thus
allowing
sensitivity
restored,
host
immunity
enhanced,
clinical
efficiency
improved.
Currently,
developments
genomics,
transcriptomics,
proteomics
available
research,
which
lead
discovery
generation
antibiotics
non-antibiotics.
However,
several
areas
their
remain
unclear.
In
effort
advance
therapies
humankind,
these
gaps
literature
need
addressed.
Pharmaceuticals,
Journal Year:
2023,
Volume and Issue:
16(7), P. 1031 - 1031
Published: July 20, 2023
A
potential
complication
of
pharmacotherapy
for
a
given
patient
is
the
possibility
various
side
effects
drugs,
which
are
manifested
in
many
ways
and
constitute
iatrogenic
causes
diseases.
Among
systemic
there
also
those
involving
urinary
tract,
although
these
less
reported
literature.
The
use
numerous
drugs—especially
anticholinergics
or
drugs
with
anticholinergic
potential,
opioid
analgesics,
non-steroidal
anti-inflammatory
antidepressants,
first-generation
antipsychotics
(classic
neuroleptics)
selected
cardiovascular
(beta-blockers,
thiazides
potassium-sparing
diuretics,
statins),
as
well
others—may
increase
risk
developing
urological
disorders,
such
retention
incontinence,
tract
infections,
urolithiasis,
erectile
dysfunction
men
retroperitoneal
fibrosis.
purpose
this
paper
to
characterise
abovementioned
drug-induced
disorders
lower
on
basis
non-systematic
literature
review.
Experimental and Therapeutic Medicine,
Journal Year:
2024,
Volume and Issue:
27(4)
Published: Feb. 14, 2024
Urinary
tract
infections
(UTIs)
are
prevalent
and
recurrent
bacterial
that
affect
individuals
worldwide,
posing
a
significant
burden
on
healthcare
systems.
The
present
study
aimed
to
explore
the
epidemiology
of
UTIs,
investigating
seasonal,
gender‑specific
age‑related
pathogen
distribution
guide
clinical
diagnosis.
Data
were
retrospectively
collected
from
electronic
medical
records
laboratory
reports
926
UTIs
diagnosed
in
Fuding
Hospital
(Fujian
University
Traditional
Chinese
Medicine,
Fuding,
China).
Bacterial
isolates
identified
using
standard
microbiological
techniques.
χ2
tests
performed
assess
associations
between
pathogens
seasons,
sex
age
groups.
Significant
found
species
seasons.
Enterococcus
faecium
exhibited
substantial
prevalence
spring
(χ2,
12.824;
P=0.005),
while
Acinetobacter
baumannii
demonstrated
increased
autumn
16.404;
P=0.001).
Female
patients
showed
higher
incidence
UTIs.
Gram‑positive
bacteria
more
males,
with
Staphylococcus
aureus
showing
male
predominance
14.607;
P<0.001).
E.
displayed
an
increase
17.775;
P<0.001),
whereas
Escherichia
coli
tended
be
younger
12.813;
P=0.005).
These
findings
highlight
complex
nature
offer
insights
for
tailored
diagnostic
preventive
strategies,
potentially
enhancing
outcomes.
Enterococcus
faecalis
is
a
bacterial
pathogen
that
can
cause
opportunistic
infections.
Studies
indicate
initial
biofilm
formation
plays
crucial
regulatory
role
in
these
infections,
as
well
colonising
and
maintaining
the
gastrointestinal
tract
commensal
member
of
microbiome
most
land
animals.
It
has
long
been
thought
vegetation
endocarditis
resulting
from
attachment
to
endocardial
endothelium
requires
some
pre-existing
tissue
damage,
animal
models
experimental
endocarditis,
mechanical
valve
damage
typically
induced
by
cardiac
catheterisation
preceding
infection.
This
section
reviews
historical
contemporary
model
studies
demonstrate
E.
ability
colonise
undamaged
endovascular
endothelial
surface
directly
produce
robust
microcolony
biofilms
encapsulated
within
bacterially
derived
extracellular
matrix.
report
both
previous
current
demonstrating
resilient
capacity
The
article
also
considers
morphological
similarities
when
develop
on
different
host
sites,
for
example
colonises
epithelium
common
vertebrate
microbiome,
lurking
plain
sight
transmitting
systemic
These
phenotypes
may
enable
organism
survive
an
unrecognised
infection
asymptomatic
subjects,
providing
infectious
resource
subsequent
clinical
process
endocarditis.